Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changes in posttraumatic stress disorder symptom severity during the COVID-19 pandemic: Ten-wave findings from a longitudinal observational cohort study of community adults.
Scarfe ML, Belisario K, Gillard J, DeJesus J, Frey BN, Van Ameringen M, McKinnon MC, Bird BM, Gohari MR, Busse JW, MacKillop J. Scarfe ML, et al. Among authors: van ameringen m. Psychiatry Res. 2023 Nov;329:115496. doi: 10.1016/j.psychres.2023.115496. Epub 2023 Sep 23. Psychiatry Res. 2023. PMID: 37797439
Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment.
Walker JR, Van Ameringen MA, Swinson R, Bowen RC, Chokka PR, Goldner E, Johnston DC, Lavallie YJ, Nandy S, Pecknold JC, Hadrava V, Lane RM. Walker JR, et al. Among authors: van ameringen ma. J Clin Psychopharmacol. 2000 Dec;20(6):636-44. doi: 10.1097/00004714-200012000-00009. J Clin Psychopharmacol. 2000. PMID: 11106135 Clinical Trial.
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.
Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ; WFSBP Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disoders; Zohar J, Hollander E, Kasper S, Möller HJ, Bandelow B, Allgulander C, Ayuso-Gutierrez J, Baldwin DS, Buenvicius R, Cassano G, Fineberg N, Gabriels L, Hindmarch I, Kaiya H, Klein DF, Lader M, Lecrubier Y, Lépine JP, Liebowitz MR, Lopez-Ibor JJ, Marazziti D, Miguel EC, Oh KS, Preter M, Rupprecht R, Sato M, Starcevic V, Stein DJ, van Ameringen M, Vega J. Bandelow B, et al. Among authors: van ameringen m. World J Biol Psychiatry. 2008;9(4):248-312. doi: 10.1080/15622970802465807. World J Biol Psychiatry. 2008. PMID: 18949648
Paroxetine-induced increase in LDL cholesterol levels.
Le Melledo JM, Mailo K, Lara N, Abadia MC, Gil L, Van Ameringen M, Baker G, Perez-Parada J. Le Melledo JM, et al. Among authors: van ameringen m. J Psychopharmacol. 2009 Sep;23(7):826-30. doi: 10.1177/0269881108094320. Epub 2008 Dec 12. J Psychopharmacol. 2009. PMID: 19074543 Clinical Trial.
146 results